1315 Capital

1315 Capital, established in 2014 and headquartered in Philadelphia, is a private equity firm specializing in growth capital investments in the healthcare sector. The firm focuses on commercial-stage companies in specialty pharmaceuticals, medical technology, and healthcare services, including digital health and cost containment businesses. 1315 Capital targets investments of $10-$20 million in companies with the potential to scale to approximately $100 million in revenue, making them attractive acquisition targets or candidates for public market access. The firm's strategy is to support high-quality management teams in rapidly growing small platform companies in a capital-efficient manner.

Jordan Brown

Principal

Edward Chan

Partner and Investment Team Member

Carter Cortazzi

Associate and Investment Team Member

Jessica Hou

Partner

Michael Koby

Co-Founder and Investment Team Member

Ryan Kraus

Vice President

Ian Li

Principal and Investment Team Member

Craig Matturro

Principal and Investment Team Member

Adele C. Oliva

Co-Founder, Partner and Member of Investment Team

Matthew Q Reber

Partner and Member of Investment Team

16 past transactions

SciSafe

Acquisition in 2024
SciSafe, Inc. is a biotechnology company that specializes in providing storage services for pharmaceutical and biological samples. Founded in 2010 and based in Cranbury, New Jersey, with an additional office in Billerica, Massachusetts, SciSafe offers a comprehensive range of services including biological storage, pharmaceutical stability testing, and cold chain logistics. The company ensures optimal storage conditions for various applications such as vaccine storage, clinical trial samples, and bulk pharmaceutical products. Additionally, SciSafe provides sample management services that allow clients to maintain inventory control and oversight of their samples throughout the storage process. With a team possessing over 60 years of combined experience in life sciences, SciSafe is dedicated to meeting the critical requirements for specimen storage and cold chain management. As of October 1, 2020, SciSafe operates as a subsidiary of BioLife Solutions, Inc.

Experic

Venture Round in 2024
Experic is a contract development and manufacturing organization (CDMO) that offers comprehensive pharmaceutical supply services, supporting all stages of a product's life cycle, from clinical trials to commercial production. The company specializes in a range of dosing and packaging formats, including capsule filling, powder and pellet dosing, as well as autoinjectors and pen assemblies. With a focus on quality and efficiency, Experic utilizes advanced equipment in its state-of-the-art Class A GMP facility to deliver high-quality products, even for expedited projects. Their services encompass process development, analytical support, clinical trial supply, vendor management, packaging, and logistics solutions. Experic is dedicated to providing personalized, hands-on assistance to clients throughout their development projects, ensuring a tailored approach to meet specific needs.

Spineology

Series A in 2024
Spineology Inc. is a medical device company specializing in anatomy-conserving technology solutions for spine surgery. Founded in 1996 and headquartered in Saint Paul, Minnesota, the company offers a range of products designed to enhance surgical efficiency and improve patient outcomes. Its product lineup includes pedicular fixation systems like Threshold and Fortress, interbody fusion solutions such as Duo and Rampart, and biologics like the Prime liquid tissue matrix and Armor amniotic wound covering. Additionally, Spineology provides a variety of surgical instruments, including the Capture facet fixation system, VIA spinous process fixation system, and Medius midline retractor system, among others. The company focuses on using minimally invasive techniques to reduce post-operative pain and facilitate quicker recovery for patients suffering from spinal-related issues.

NutriSense

Series A in 2022
NutriSense, established in 2019 and headquartered in Chicago, Illinois, specializes in AI-driven corporate wellness programs. The company offers a comprehensive solution comprising continuous glucose monitoring (CGM) devices, a tracking app for diet management, and personalized consultations with registered dietitians. NutriSense leverages machine learning technology to provide real-time blood glucose level monitoring and tailored nutrition insights, aiming to empower individuals to achieve their health goals.

Homestead Smart Health Plans

Acquisition in 2021
Homestead Smart Health Plans specializes in providing health benefit plan administration services tailored for self-funded employer groups. The company offers transparent and sustainable health plans based on a reference-based repricing system, which enables employers to manage their healthcare expenses effectively. In addition to its core health plans, Homestead includes stop-loss insurance to protect against catastrophic losses and provides third-party administration services. This comprehensive approach allows employers to operate self-funded health plans while achieving significant savings in healthcare costs.

Onkos Surgical

Series C in 2021
Onkos Surgical Inc. is a privately-held company based in Parsippany, New Jersey, focused on providing advanced technologies and solutions for surgical oncologists. Founded in 2014, Onkos Surgical is dedicated to transforming the treatment of musculoskeletal cancers and complex orthopedic conditions. The company offers innovative products such as GenVie, a magnesium bone scaffolding technology, and the ELEOS Proximal Tibia, a 3D printed limb salvage replacement. By leveraging cutting-edge techniques in virtual surgical planning, 3D modeling and printing, and personalized surgical planning, Onkos Surgical aims to enhance patient outcomes and improve the overall experience for both patients and healthcare professionals.

miraDry

Acquisition in 2021
miraDry is a only FDA cleared device to reduce underarm sweat, odor and permanently reduce hair of all colors. miraDry non-invasive procedure is safe and highly efficacious with a proven commercial and clinical track record.

Interpace Biosciences

Post in 2020
Interpace Biosciences is a leader in the life sciences sector, specializing in complex molecular analysis to facilitate the early diagnosis and treatment of cancer. The company operates through its Interpace Diagnostics business unit, which offers clinically beneficial molecular diagnostic tests and pathology services. Among its notable products are PancraGen, ThyGeNext, ThyraMir, RespriDX, and BarreGen, all designed to evaluate cancer risk and guide personalized treatment strategies. Interpace Biosciences utilizes advanced technology in personalized medicine, focusing on genomic tests aimed at early detection for patients with indeterminate biopsy results or those at high risk for cancer. Through its comprehensive approach, the company plays a critical role in enhancing patient diagnosis and management in oncology.

Encore Dermatology

Debt Financing in 2019
Encore Dermatology is a privately held, fully-integrated dermatology company based in Malvern, Pennsylvania, established in 2015. The company specializes in delivering prescription therapies and medical devices to dermatologists, focusing on a variety of medical dermatology products. These offerings address several topical disease states, including conditions like acne and atopic dermatitis, thereby facilitating enhanced skincare and treatment options for patients. Through its comprehensive approach, Encore Dermatology aims to improve patient outcomes and streamline the dermatological care process.

Biocoat

Acquisition in 2019
Biocoat is a developer and manufacturer of specialized biomaterial coatings for medical devices, focusing on custom-engineered solutions that meet specific client requirements. The company is particularly known for its hydrophilic coatings, which are designed to be lubricious, abrasion-resistant, non-thrombogenic, and biocompatible. These coatings enhance the performance of various medical devices, such as vascular catheters and guide wires, by minimizing friction and facilitating smoother movement through the body. Biocoat's innovative products aim to improve the safety and effectiveness of medical interventions.

Centurion Service Group

Acquisition in 2018
Centurion Service Group, LLC is a leading used medical equipment auction house based in Franklin Park, Illinois, with additional locations in Chicago, Las Vegas, South Florida, Dallas, Columbus, and Salt Lake City. Established in 2001, the company specializes in the sale of a wide variety of medical equipment, including radiology machines, MRI and CT machines, and surgical instruments. Centurion facilitates the buying and selling of surplus medical equipment for healthcare facilities, providing services such as certified appraisals, asset inventory management, and equipment relocation. With a robust auction platform, it sells over 8,000 pieces of medical equipment monthly, serving as a comprehensive source for healthcare providers seeking both refurbished and used equipment. By partnering with hospitals and surgery centers, Centurion helps unlock the value of unused medical assets, thereby enhancing financial resources for its clients.

Misonix

Post in 2017
Misonix is a leading medical device company specializing in ultrasonic surgical technology. The company designs, manufactures, and markets innovative devices that enhance clinical outcomes in various surgical fields, including neurosurgery, orthopedic surgery, plastic surgery, and wound care. Misonix's product portfolio features advanced ultrasonic platforms such as aspirators for soft and hard tissue removal, instruments for laparoscopic procedures, and devices for wound cleansing and debridement. Additionally, its offerings include tools for precision bone cutting and sculpting, as well as liposuction instruments aimed at improving body aesthetics. Notable products include BoneScalpel, NeXus, Sequel, SonaStar, SonicOne, Theragenesis, TheraSkin, and Therion. Misonix serves a global market, with a presence in regions such as the United States and the United Kingdom, contributing to the overall value of the healthcare system.

Colorescience

Series C in 2017
Colorescience, Inc. is a Carlsbad, California-based company that specializes in producing and selling mineral-based cosmetics and sunscreen products. Founded in 2000, Colorescience offers a range of products including treatment solutions for pigmentation, redness, dark circles, and signs of aging, as well as products designed for sensitive, oily, and dry skin. Its offerings include UV protectors, primers, foundations, and enhancers, all formulated with high-quality, dermatologist-recommended ingredients such as minerals, antioxidants, and botanicals. The company differentiates itself in the luxury aesthetic makeup market by emphasizing efficacy, convenience, and simplicity of use. Colorescience distributes its products through a network of licensed physicians, luxury spas, retailers, and online platforms, with a commitment to addressing skin health and reducing the risk of skin cancer.

Onkos Surgical

Series B in 2017
Onkos Surgical Inc. is a privately-held company based in Parsippany, New Jersey, focused on providing advanced technologies and solutions for surgical oncologists. Founded in 2014, Onkos Surgical is dedicated to transforming the treatment of musculoskeletal cancers and complex orthopedic conditions. The company offers innovative products such as GenVie, a magnesium bone scaffolding technology, and the ELEOS Proximal Tibia, a 3D printed limb salvage replacement. By leveraging cutting-edge techniques in virtual surgical planning, 3D modeling and printing, and personalized surgical planning, Onkos Surgical aims to enhance patient outcomes and improve the overall experience for both patients and healthcare professionals.

JDS Therapeutics

Private Equity Round in 2015
JDS Therapeutics, LLC is a healthcare company based in Purchase, New York, that develops and markets innovative healthcare products for physicians and healthcare professionals. Founded in 2011, the company specializes in nutritional ingredients and pharmaceutical products targeting diabetes, women’s health, cardiovascular diseases, and weight management. Among its offerings are ZERAMAX, a medical food designed for diabetes management; JDS-CR-002, an oral prescription drug; JDS-CR-102, an injectable prescription drug; JDS-SI-002, a medical food aimed at osteoporosis; and JDS-CR-007, a nutritional supplement for managing hot flashes. JDS Therapeutics is also notable for its extensive intellectual property portfolio, owning over 100 issued and pending patents related to natural, bioactive compounds.

Onkos Surgical

Series A in 2015
Onkos Surgical Inc. is a privately-held company based in Parsippany, New Jersey, focused on providing advanced technologies and solutions for surgical oncologists. Founded in 2014, Onkos Surgical is dedicated to transforming the treatment of musculoskeletal cancers and complex orthopedic conditions. The company offers innovative products such as GenVie, a magnesium bone scaffolding technology, and the ELEOS Proximal Tibia, a 3D printed limb salvage replacement. By leveraging cutting-edge techniques in virtual surgical planning, 3D modeling and printing, and personalized surgical planning, Onkos Surgical aims to enhance patient outcomes and improve the overall experience for both patients and healthcare professionals.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.